Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.
To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance....
Main Authors: | , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2017-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC5515424?pdf=render |
id |
doaj-7af8b3749b5d40adab4b55aede43e046 |
---|---|
record_format |
Article |
spelling |
doaj-7af8b3749b5d40adab4b55aede43e0462020-11-24T21:50:03ZengPublic Library of Science (PLoS)PLoS ONE1932-62032017-01-01127e018121110.1371/journal.pone.0181211Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer.Ippokratis MessaritakisEleni PolitakiAthanasios KotsakisEleftheria-Kleio DermitzakiFilippos KoinisEleni LagoudakiAnastasios KoutsopoulosGalatea KallergiJohn SouglakosVassilis GeorgouliasTo evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance.CTCs from 108 chemotherapy-naïve patients with SCLC were analyzed by double immunofluorescence staining using anti-Ki67, anti-M30, anti-Vimentin along with anti-CKs antibodies. In 83 patients CTCs were also enumerated using the CellSearch.Sequential samples were available from 76 and 48 patients after one-treatment cycle and on disease progression (PD), respectively, for immunofluorescence and from 50 and 36 patients after one-cycle and on PD, respectively, for CellSearch. At baseline, 60.2% of the patients had detectable CTCs by either method. Both proliferative (CK67+) and non-proliferative (Ki67-), apoptotic (M30+) and non-apoptotic (M30-) as well as EMT (Vim+) CTCs were present in the same patient. Among 22 patients without detectable CTCs by CellSearch, CK+/Ki67+ and CK+/Vim+ CTCs could be detected in 6 (27.3%) and 6 (27.3%) patients, respectively. One-chemotherapy cycle reduced both the incidence of detection (p<0.001) and the absolute number (p<0.001) of CTCs; conversely, on PD both the incidence of detection and the number of CTCs were significantly increased (p = 0.002 and p = 0.04, respectively). Multivariate analysis revealed that the increased number of Vim+ CTCs at baseline and of non-apoptotic CTCs on PD could be emerged as independent prognostic factors associated with decreased OS(p = 0.009 and p = 0.023, respectively).CK+/Ki67+, CK+/M30+ and CK+/Vim+ CTCs represent distinct subpopulations of CTCs in patients with SCLC, can be detected even in the absence of detectable CTCs by CellSearch; CK+/Ki67+ and CK+/Vim+ CTCs are associated with unfavorable clinical outcome.http://europepmc.org/articles/PMC5515424?pdf=render |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Ippokratis Messaritakis Eleni Politaki Athanasios Kotsakis Eleftheria-Kleio Dermitzaki Filippos Koinis Eleni Lagoudaki Anastasios Koutsopoulos Galatea Kallergi John Souglakos Vassilis Georgoulias |
spellingShingle |
Ippokratis Messaritakis Eleni Politaki Athanasios Kotsakis Eleftheria-Kleio Dermitzaki Filippos Koinis Eleni Lagoudaki Anastasios Koutsopoulos Galatea Kallergi John Souglakos Vassilis Georgoulias Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. PLoS ONE |
author_facet |
Ippokratis Messaritakis Eleni Politaki Athanasios Kotsakis Eleftheria-Kleio Dermitzaki Filippos Koinis Eleni Lagoudaki Anastasios Koutsopoulos Galatea Kallergi John Souglakos Vassilis Georgoulias |
author_sort |
Ippokratis Messaritakis |
title |
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
title_short |
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
title_full |
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
title_fullStr |
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
title_full_unstemmed |
Phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
title_sort |
phenotypic characterization of circulating tumor cells in the peripheral blood of patients with small cell lung cancer. |
publisher |
Public Library of Science (PLoS) |
series |
PLoS ONE |
issn |
1932-6203 |
publishDate |
2017-01-01 |
description |
To evaluate the phenotypic heterogeneity of circulating tumor cells (CTCs) based on the expression of proliferative, apoptotic and Epithelial-to-Mesenchymal Transmission (EMT) markers during front-line treatment in patients with small cell lung cancer (SCLC) and to evaluate their clinical relevance.CTCs from 108 chemotherapy-naïve patients with SCLC were analyzed by double immunofluorescence staining using anti-Ki67, anti-M30, anti-Vimentin along with anti-CKs antibodies. In 83 patients CTCs were also enumerated using the CellSearch.Sequential samples were available from 76 and 48 patients after one-treatment cycle and on disease progression (PD), respectively, for immunofluorescence and from 50 and 36 patients after one-cycle and on PD, respectively, for CellSearch. At baseline, 60.2% of the patients had detectable CTCs by either method. Both proliferative (CK67+) and non-proliferative (Ki67-), apoptotic (M30+) and non-apoptotic (M30-) as well as EMT (Vim+) CTCs were present in the same patient. Among 22 patients without detectable CTCs by CellSearch, CK+/Ki67+ and CK+/Vim+ CTCs could be detected in 6 (27.3%) and 6 (27.3%) patients, respectively. One-chemotherapy cycle reduced both the incidence of detection (p<0.001) and the absolute number (p<0.001) of CTCs; conversely, on PD both the incidence of detection and the number of CTCs were significantly increased (p = 0.002 and p = 0.04, respectively). Multivariate analysis revealed that the increased number of Vim+ CTCs at baseline and of non-apoptotic CTCs on PD could be emerged as independent prognostic factors associated with decreased OS(p = 0.009 and p = 0.023, respectively).CK+/Ki67+, CK+/M30+ and CK+/Vim+ CTCs represent distinct subpopulations of CTCs in patients with SCLC, can be detected even in the absence of detectable CTCs by CellSearch; CK+/Ki67+ and CK+/Vim+ CTCs are associated with unfavorable clinical outcome. |
url |
http://europepmc.org/articles/PMC5515424?pdf=render |
work_keys_str_mv |
AT ippokratismessaritakis phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT elenipolitaki phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT athanasioskotsakis phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT eleftheriakleiodermitzaki phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT filipposkoinis phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT elenilagoudaki phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT anastasioskoutsopoulos phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT galateakallergi phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT johnsouglakos phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer AT vassilisgeorgoulias phenotypiccharacterizationofcirculatingtumorcellsintheperipheralbloodofpatientswithsmallcelllungcancer |
_version_ |
1725885643289001984 |